Evidence map›Paper›PMID 31267362›Full record

ArticleInternational journal of clinical pharmacy2019

Pharmacogenomics-based practice in North Cyprus: its adoption by pharmacists and their attitudes and knowledge.

Louai Alsaloumi, Abdikarim Abdi, Özgür Tosun, Bilgen Başgut

Abstract read
PubMed Publisher
In one paragraph

Article in International journal of clinical pharmacy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. An objective evaluation of fundamental pharmacogenomics knowledge among pharmacists and pharmacy students.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Louai AlsaloumiDepartment of Clinical Pharmacy, Faculty of Pharmacy, Near East University, Near East Boulevard, Mersin 10, P.O. Box: 922022, Nicosia, Northern Cyprus, Turkey. louaisaloumi@hotmail.com.ORCID http://orcid.org/0000-0003-2936-8178
Abdikarim AbdiDepartment of Clinical Pharmacy, Faculty of Pharmacy, Near East University, Near East Boulevard, Mersin 10, P.O. Box: 922022, Nicosia, Northern Cyprus, Turkey.
Özgür TosunDepartment of Biostatistics, Faculty of Medicine, Near East University, Near East Boulevard, Mersin 10, P.O. Box: 922022, Nicosia, Northern Cyprus, Turkey.
Bilgen BaşgutDepartment of Clinical Pharmacy, Faculty of Pharmacy, Near East University, Near East Boulevard, Mersin 10, P.O. Box: 922022, Nicosia, Northern Cyprus, Turkey.
Near East University · CY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background Pharmacogenomics is a branch of biotechnological science integrating medicine, pharmacology, and genomics techniques. Moreover, it focuses on creating drug therapies in order to analyze genetic differences in patients causing various responses to a single therapeutic regimen. Objective This cross sectional study aimed to examine the attitude, knowledge and adoption among pharmacists in North Cyprus and the most appropriate method to improve education among them. Setting Community pharmacy setting. Method A total of 103 out of 140 pharmacists responded to a pre-tested and validated questionnaire consisting of 25 items during July through September 2016. Main outcome measure Pharmacists attitude, knowledge and adoption towards pharmacogenomic tests. Result Data showed that most of the pharmacists in North Cyprus had positive attitude and knowledge scores with mean value of 28.3 ± 5.3 (out of 40) and 6.9 ± 0.8 (out of 10) respectively, further findings showed that there is a significant difference among age groups in their total attitude score (p < 0.05). Conclusion Even though pharmacogenomics is a field promising a variety of benefits, it is vital to implement it in clinical settings in order to improve outcomes. Our findings highlight the necessity for more education on the availability and interpretation of pharmacogenomics tests.

Indexed as

Health Knowledge, Attitudes, PracticePharmacistsPharmacogeneticsAdultAge FactorsCross-Sectional StudiesCyprusEducation, PharmacyFemaleGenetic TestingHumansMaleMiddle AgedPharmaciesProfessional PracticeProspective StudiesAttitudeEducationNorth CyprusPharmacistPharmacogenomicsPharmacy practice

Identifiers

PMID31267362
OpenAlexW2954815767

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.